Pathology-supported genetic testing for the application of breast cancer pharmacodiagnostics: family counselling, lifestyle adjustments and change of medication

CONCLUSION: Validation of PSGT as a three-pronged pharmacodiagnostics tool for generation of adaptive reports and data reinterpretation during follow-up represents a new paradigm in personalised medicine, exposing significant limitations to overcome.PMID:37060281 | DOI:10.1080/14737159.2023.2203815

Source: Expert Review of Molecular Diagnostics - April 15, 2023 Category: Laboratory Medicine Authors: Abisola O Okunola Karin J Baatjes Annalise E Zemlin Rispah Torrorey-Sawe Magda Conradie Martin Kidd Rajiv T Erasmus Nerina C van der Merwe Maritha J Kotze Source Type: research